Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesAdvantis Corp

Advantis Corp

Healthcare Drug Manufacturers - Specialty & Generic
PortfolioPortfolio WatchlistWatchlist
Company price
0.0 USD 0.00(0%)
Last update at 2026-11-11T21:00:00Z
VOLUME
200692
Market Cap
0.01M

Momentum Score

…

Advantis Corp. develops and markets products focusing on medical cannabis, research, and pharmaceutical sectors. The company offers pain management and healthcare solutions. Advantis Corp. was formerly known as Ramoil Management, Ltd. and changed its name to Advantis Corp. in December 2015. Advantis Corp. is based in Newport Beach, California.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

52 Week Price Range
-
Low
-
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Advantis Corp (OTC: ADVT) is an OTC-listed company for which public disclosures and verifiable operational details are limited, making its core business activities and financial profile unclear. Potential long-term growth drivers are therefore uncertain, though investors may find exposure to an underfollowed microcap attractive if the company clarifies strategy, secures financing, or demonstrates operational progress.

Primary investment risks include very low liquidity, limited analyst and regulatory scrutiny, heightened volatility and potential for significant dilution or difficulty accessing reliable financial information common to OTC microcap issuers.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
-
Dividend Yield
-
Revenue TTM
0.00M
Revenue Per Share
-
Gross Profit TTM
0.00M
Debt / Equity
-0.56
ROE
-
Net Debt
0.42M
ROCE
4.00%
Diluted EPS TTM
-

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax - - - - -0.02M
Net income - - - - -0.02M
Gross profit - - - - 0.76M
Ebitda - - - - -0.02M
Depreciation and amortization 0.23M 0.24M 0.21M 0.17M -
Operating income - - - - -0.02M
Other operating expenses - - - - 0.85M
Interest expense - - - - 0.00M
Total revenue - - - - 0.83M
Total operating expenses - - - - 0.79M
Cost of revenue - - - - 0.06M
Total other income expense net - - - - -0.00M
Breakdown 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31
Type yearly yearly yearly yearly yearly
Date 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31
Total assets 0.54M 0.27M 0.05M 0.01M 0.00M
Other current assets 0.22M 0.10M 0.00M - -
Total liab 1.84M 1.52M 1.34M 1.29M 1.39M
Total stockholder equity -1.30M -1.26M -1.29M -1.28M -1.39M
Other current liab 1.12M - - - -
Common stock 0.10M 0.10M 0.08M 0.07M 0.07M
Retained earnings -1.65M -1.65M -1.53M -1.43M -1.53M
Cash 0.30M 0.14M 0.01M 0.01M 0.00M
Total current liabilities 1.12M 0.80M 0.48M 0.43M 1.39M
Net debt 0.42M - - - -
Short term debt - 0.36M 0.25M 0.36M 0.16M
Short long term debt - 0.36M 0.25M 0.36M 0.16M
Short long term debt total 0.72M - - - -
Other stockholder equity 0.25M - - - -
Total current assets 0.54M 0.27M 0.05M 0.01M 0.00M
Net tangible assets - -1.26M -1.29M -1.28M -1.39M
Net receivables 0.03M 0.02M 0.03M - -
Long term debt - 0.72M 0.85M 0.85M -
Inventory - 0.01M 0.01M - -
Accounts payable 0.00M 0.44M 0.23M 0.07M 1.23M
Accumulated other comprehensive income -0.00M - - - -
Breakdown 2019-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31
Type yearly yearly yearly yearly yearly
Date 2019-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31
Change to liabilities - 0.19M 0.07M -0.98M 0.06M
Total cashflows from investing activities - -0.10M -0.10M -0.10M -
Net borrowings - - -0.02M 0.88M 0.88M
Total cash from financing activities - 0.03M 0.08M 0.88M 0.02M
Change to operating activities - 0.02M -0.04M -0.04M -0.04M
Net income - -0.11M -0.11M 0.11M -0.08M
Change in cash - 0.13M 0.00M 0.01M 0.00M
Begin period cash flow 0.30M - - - -
End period cash flow 0.30M - - - -
Total cash from operating activities - 0.09M -0.08M -0.87M -0.02M
Sale purchase of stock - 0.13M 0.10M 0.10M 0.02M
Capital expenditures 0.00M 0.00M 0.00M 0.00M 0.00M

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
MKKGY
Merck KGaA ADR		 -0.74
2.19%		 33.06 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien		 -
-%		 170.05 24.86 15.11 3.13 1.98 3.08 18.89
TAK
Takeda Pharmaceutical Co Ltd ADR		 0.34
1.66%		 21.18 - 10.96 0.01 1.20 2.94 23.11
TKPHF
Takeda Pharmaceutical Co. Ltd.		 -
-%		 41.72 - 10.66 0.01 1.16 2.94 23.11

Profile*

Advantis Corp

Advantis Corp. develops and markets products focusing on medical cannabis, research, and pharmaceutical sectors. The company offers pain management and healthcare solutions. Advantis Corp. was formerly known as Ramoil Management, Ltd. and changed its name to Advantis Corp. in December 2015. Advantis Corp. is based in Newport Beach, California.

1048 Irvine Avenue, Newport Beach, CA, United States, 92660

949-354-3585

https://www.advantiscorp.com

5

Name Title Year Born
Mr. Darren Cherry Chief Exec. Officer NA
Mr. Geoffrey Broderick Corp. Counsel NA
Mr. Chris Thue Chief Compliance Officer of Operations NA
Mr. Darren Cherry Chief Executive Officer NA
Mr. Geoffrey Broderick Corporate Counsel NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

CJT
CAD 111.15
+12.71%
CLS
CAD 374.20
+8.33%
GRZ
CAD 4.90
+7.46%
CTC-A
CAD 218.05
+6.38%
FEC
CAD 7.42
+5.85%
TF
CAD 4.13
-19.65%
TLO
CAD 5.98
-15.06%
FSZ
CAD 2.45
-14.04%
XNDU
CAD 3.60
-8.86%
ITR
CAD 2.75
-8.50%

Equity Sectors*

  • Basic Materials

    -2.63%

  • Communication Services

    -0.79%

  • Consumer Cyclical

    +0.08%

  • Consumer Defensive

    -0.12%

  • Energy

    +0.52%

  • Financial Services

    -1.15%

  • Healthcare

    -1.74%

  • Industrials

    -0.64%

  • Real Estate

    -0.12%

  • Technology

    -0.51%

  • Utilities

    -0.02%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…